Drugs / Yellow fever vaccine (produced on serum-free Vero cells)
Yellow fever vaccine (produced on serum-free Vero cells)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05011123 | Oct 2021 → May 2022 overdue | yellow fever | Sanofi Pasteur, a Sanofi Company | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yellow fever vaccine (produced on serum-free Vero cells) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05011123 ↗ |
| Modality | Vaccine | “vYF vaccine” NCT05011123 ↗ |
| Route | Subcutaneous | “single subcutaneous injection of either the vYF vaccine” NCT05011123 ↗ |